This study examined the acceptability and feasibility of introducing early medical abortion with mifepristone and misoprostol in Azerbaijan. All women were given the option of taking the misoprostol at home, and women in two of the three study sites were also given the option of taking the mifepristone at home. Efficacy and satisfaction were both very high, and a large proportion of women (74% of those eligible) chose home administration of both drugs.
The European Journal of Contraception and Reproductive Health Care, 2014; Early Online: 1–8.
Access the abstract.